Myeloid cell thrombus and fetal vascular malperfusion in placentas with transient abnormal myelopoiesis

[1]  Jae Wook Lee,et al.  Marked thrombocytosis resulting in pseudohyperkalemia in a neonate with transient abnormal myelopoiesis , 2021, Pediatric blood & cancer.

[2]  Y. Hayashi,et al.  Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution , 2021, International Journal of Hematology.

[3]  Masanaka Sugiyama,et al.  Factors influencing platelet normalization of transient abnormal myelopoiesis , 2020, Pediatrics international : official journal of the Japan Pediatric Society.

[4]  Asangi R. Kumarapeli,et al.  Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis. , 2020, Archives of pathology & laboratory medicine.

[5]  Y. Asada,et al.  CD39 downregulation in chronic intervillositis of unknown etiology , 2019, Virchows Archiv.

[6]  R. Redline,et al.  Fetal vascular malperfusion, an update , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  Michael L Wilson,et al.  Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature. , 2016, American journal of clinical pathology.

[8]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[9]  Y. Ogiso,et al.  Thrombocytosis in a newborn with Down syndrome and transient abnormal myelopoiesis , 2016, British journal of haematology.

[10]  D. Treaba,et al.  Extensive Placental Choriovascular Infiltration by Maturing Myeloid Cells in down Syndrome-Associated Transient Abnormal Myelopoiesis , 2015, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[11]  P. Iyer,et al.  Congenital GATA1-mutated myeloproliferative disorder in trisomy 21 complicated by placental fetal thrombotic vasculopathy. , 2014, Human pathology.

[12]  K. Kagan,et al.  Transient abnormal myelopoiesis/acute megakaryoblastic leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing , 2014, Leukemia.

[13]  J. Choi,et al.  Trisomy 21–Associated Transient Abnormal Myelopoiesis Involving the Maternal Space of the Placenta: A Case Report and Literature Review , 2014, Pediatric and Developmental Pathology.

[14]  S. Izraeli,et al.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. , 2009, Blood.

[15]  C. Spong,et al.  The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. , 2008, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[16]  P. Vyas,et al.  Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome , 2007, Nature Clinical Practice Oncology.

[17]  K. Nicolaides,et al.  Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. , 2000, Placenta.

[18]  W. Dittman,et al.  Transient myeloproliferative disease of the newborn: case report with placental, cytogenetic, and flow cytometric findings. , 2000, Human pathology.

[19]  C. Gocke,et al.  PLACENTAL PATHOLOGY IN MATERNAL AND NEONATAL MYELOPROLIFERATIVE DISORDERS , 1998, Obstetrics and gynecology.

[20]  M. Evans,et al.  Trisomy 21 placentas: histopathological and immunohistochemical findings using proliferating cell nuclear antigen. , 1997, Fetal diagnosis and therapy.

[21]  C. Sung,et al.  Reference values for singleton and twin placental weights. , 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

[22]  M. Bufano.  [Tumors of the bone marrow]. , 1955, Rassegna clinico-scientifica.